IGM Biosciences Inc. (IGMS) Misses Q3 EPS by 21c

IGM Biosciences Inc. (NASDAQ: IGMS) reported Q3 EPS of ($1.01), $0.21 worse than the analyst estimate of ($0.80). Revenue for the quarter came in at $520 thousand versus the consensus estimate of $230.56 thousand.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.

You May Also Be Interested In

• Doncasters (DPC) indicating open around $40, IPO priced at $33
• Compass (COMP) spreader of July 10 and 12 calls as share price up 1.6%
• SpaceX credit-default swaps start trading after bond sale